Evotec Announces Progress in its Collaboration with Bristol Myers Squibb
Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there remains a significant unmet medical need for therapies that slow down or reverse disease progression.
Bristol Myers Squibb | 12/08/2024 | By Aishwarya | 207
Bristol Myers Squibb Gets US FDA Approval for Breyanzi
Bristol Myers Squibb has declared that US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi.
Bristol Myers Squibb | 17/05/2024 | By Aishwarya | 219
Scenic Biotech Enters into Research Partnership with Bristol Myers Squibb
Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.
Bristol Myers Squibb | 01/05/2024 | By Aishwarya | 218
Bristol Myers Squibb to invest Rs 800 Cr in setting up R&D facility in Telangana
The company intends to begin operations in Hyderabad later in 2023
Bristol Myers Squibb | 24/02/2023 | By Sudeep Soparkar | 497
Autoimmune drug by Bristol Myers shows potential in lupus
Deucravacitinib is one of nine new drugs that Bristol Myers executives believe will help offset revenue losses
Bristol Myers Squibb | 08/06/2022 | By Sudeep Soparkar | 539
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy